Pharmacists in West Bend, Wisconsin


45 Pharmacists found in West Bend
female pharmacist

Dr. Mindy Eichinger, PHARMD


Pharmacist
3200 Pleasant Valley Rd Ste 1a, West Bend, WI 53095
262-836-5411    

male pharmacist

Mitchell Cherney, PHARMD


Pharmacist
2180 S Main St, West Bend, WI 53095
262-334-8510    

female pharmacist

Morgan Ann Birnschein, PHARMD


Pharmacist
1515 W Paradise Dr, West Bend, WI 53095
262-334-9860    



female pharmacist

Dr. Morgan Byron, PHARM.D.


Pharmacist
1720 W Washington St, West Bend, WI 53095
262-438-1120     262-438-1126

male pharmacist

Paul Friederichs, RPH


Pharmacist
907 Foxland Pl, West Bend, WI 53095
414-587-3160    

male pharmacist

Paul Szemraj, RPH


Pharmacist
1921 S Main St, West Bend, WI 53095
262-338-1156    

female pharmacist

Mrs. Penny Nickel Biersach


Pharmacist
5595 County Road Z, West Bend, WI 53095
262-306-2140     262-306-2141

male pharmacist

Robert F Kossow, RPH


Pharmacist
907 Foxland Pl, West Bend, WI 53095
414-587-3154     262-338-3639

male pharmacist

Dr. Robert Moresco, PHARM. D.


Pharmacist
1921 S Main St, West Bend, WI 53095
262-338-1156     262-338-2497

female pharmacist

Siok-hiok Siau


Pharmacist
1710 S Main St, West Bend, WI 53095
262-338-0222     262-338-3505

male pharmacist

Mr. Warren Richard Stern, RPH


Pharmacist
1720 W Washington St, West Bend, WI 53095
262-438-1120    

male pharmacist

Warren W Samplaski, RPH


Pharmacist
205 Valley Ave, West Bend, WI 53095
262-338-2311    

male pharmacist

Mr. William John Elliott, R.PH.


Pharmacist
907 Foxland Pl, West Bend, WI 53095
414-587-3160     262-338-3639


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.